Additional file 1 of Targeting serine synthesis pathway to reverse paclitaxel resistance in NSCLC with combination of paclitaxel and anlotinib

Figshare 2026 Open access

Read full text

Authors: Mengting Yu, Yanyun Hong, Qingshan Pan, Pengwu Zheng, Yingxing He, Wufu Zhu, Shan Xu, QiaoLi Lv

DOI: 10.6084/m9.figshare.31246434

Cited by: 0

Fields of Study & Subjects

Lung Cancer Treatments and Mutations Cancer Hypoxia and Metabolism Lipids